Novo Nordisk A/S (NYSE: NVO) is one of the top low volatility healthcare stocks to buy now. In a report released on July 17, ...

Novo Nordisk faces challenges in the competitive GLP-1 market, but its strong brand and R&D create opportunities for ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...